Figure 1.
Flow chart using the PRISMA statement for the systematic review.
Table 1.
Characteristics and Methods Used For Developing the 11 Clinical Practice Guidelines.
Table 2.
Domain Scores (%) for the 11 Clinical Practice Guidelines Using the AGREE-II Instrument.
Table 3.
Quality of the 11 Hypertension Clinical Practice Guidelines for the six domains of the AGREE-II Instrument (D1–D6) and the Overall Impression of the 4 Assessors.
Table 4.
Strength of the recommendations stated in the Malaysian and Canadian Clinical Practice Guidelines.*
Table 5.
Recommendations from Clinical Practice Guidelines About Diagnosis and Assessment of Patients with Hypertension.
Table 6.
Recommendations from Clinical Practice Guidelines about Managing Patients with Hypertension.